Patents by Inventor Henrik Daver

Henrik Daver has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Leucine-rich repeat kinase 2 (LRRK2) inhibitors
    Patent number: 11958865
    Abstract: The present invention is directed to compounds of formula IIa These compounds are considered useful for the treatment of diseases associated with leucine-rich repeat kinase 2 (LRRK2) such as Parkinson's disease. Furthermore, the invention relates to pharmaceutical compositions comprising said compounds.
    Type: Grant
    Filed: September 14, 2023
    Date of Patent: April 16, 2024
    Assignee: H. Lundbeck A/S
    Inventors: Thomas Jensen, Thomas Andersen, Mikkel Jessing, Jacob Nielsen, Henrik Daver, Christopher Richard Jones